Mc Gowan Group Asset Management, Inc. Eli Lilly & CO Transaction History

Mc Gowan Group Asset Management, Inc.

$613 Million
Q3 2024

A detailed history of Mc Gowan Group Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mc Gowan Group Asset Management, Inc. holds 21,802 shares of LLY stock, worth $17.3 Million. This represents 3.15% of its overall portfolio holdings.

Number of Shares

21,802

Previous 21,928 0.57%

Holding current value

$17.3 Million

Previous $19.9 Million 2.71%

% of portfolio

3.15%

Previous 3.4%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $97,289 - $120,962	-126 Reduced 0.57%	21,802 $19.3 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $202,238 - $253,622	-279 Reduced 1.26%	21,928 $19.9 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $19,542 - $26,145	-33 Reduced 0.15%	22,207 $17.3 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $33,086 - $39,005	-63 Reduced 0.28%	22,240 $13 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $47,382 - $65,323	-109 Reduced 0.49%	22,303 $12 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $36,476 - $48,773	104 Added 0.47%	22,412 $10.5 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $22,365 - $26,267	72 Added 0.32%	22,308 $7.66 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $964 - $1,124	3 Added 0.01%	22,236 $8.13 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $176,702 - $201,370	-596 Reduced 2.61%	22,233 $7.19 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $7,804 - $9,163	28 Added 0.12%	22,829 $7.4 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $7,040 - $8,749	-30 Reduced 0.13%	22,801 $6.53 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $4,721 - $5,859	21 Added 0.09%	22,831 $6.31 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $6,426 - $7,908	29 Added 0.13%	22,810 $5.27 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $53,262 - $68,894	-295 Reduced 1.28%	22,781 $5.23 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $1,478 - $1,914	9 Added 0.04%	23,076 $4.31 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $29,353 - $38,841	-225 Reduced 0.97%	23,067 $3.9 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $139,055 - $160,842	951 Added 4.26%	23,292 $3.45 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $19,917 - $23,970	146 Added 0.66%	22,341 $3.67 Million
Q1 2020 May 18, 2020	BUY	$119.05 - $147.35 $164,765 - $203,932	1,384 Added 6.65%	22,195 $3.08 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $9,622 - $11,918	-90 Reduced 0.43%	20,811 $2.74 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $106 - $116	1 Added 0.0%	20,901 $2.34 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $3,323 - $3,879	-30 Reduced 0.14%	20,900 $2.32 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $44,372 - $49,710	-419 Reduced 1.96%	20,930 $2.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,349	21,349 $1.76 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Gowan Group Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Gowan Group Asset Management, Inc. with notifications on news.

Account

Mc Gowan Group Asset Management, Inc. Eli Lilly & CO Transaction History